Past events
12th International mRNA Health Conference
November 12-14, 2024
Boston, USA
- Press Release
- Conference Website
- CureVac's tailored LNP platforms to deliver mRNA for prophylactic and therapeutic applications
- Development of a multiepitope mRNA cancer vaccine for glioblastoma - first results of Phase I human study
- An mRNA-based FimH ferritin nanoparticle vaccine against UPEC is highly immunogenic in rodents
- mRNA sequence parameters and formulation optimization increase mRNA therapeutics performance
- Enhancing TCRtg T cell therapy efficacy in solid tumors using mRNA-based vaccination
39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
November 8-10, 2024
Houston, USA
- Press Release
- Conference Website
- Preliminary immunogenicity results from the dose escalation phase of a first-in-human study of the mRNA-based cancer vaccine CVGBM in patients with newly diagnosed MGMT-unmethylated glioblastoma
- mRNA vaccination enhances TCRtg T cell therapy efficacy in solid tumors
- Identification and validation of a T cell receptor recognizing shared HLA-A02:01 presented epitope from TP53 frameshift
Second Quarter of 2024 Financial Results and Business Update – Press Release Only
August 15, 2024
Tübingen
Goldman Sachs 45th Annual Global Healthcare Conference
June 12, 2024
Miami
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
First Quarter of 2024 Financial Results and Business Update – Press Release Only
May 23, 2024
Tübingen
Van Lanschot Kempen Life Sciences Conference
April 16, 2024
Amsterdam
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Jefferies Biotech on the Bay Miami Summit
March 12, 2024
Miami
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Leerink Partners Global Biopharma Conference
March 11, 2024
Miami
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
February 7, 2024
New York
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
J.P. Morgan 42nd Annual Healthcare Conference 2024 San Francisco
January 8 to 11, 2024
The CureVac executive management team will be on the ground in San Francisco during the week of the JP Morgan Healthcare Conference, participating in Stern Investor Relations’s corporate access event. We welcome the opportunity to connect in person. To request a meeting, please contact the Stern IR team via the link below.
Downloads
- Pressemitteilung
- Präsentation (Englischsprachig)
- Transkript (Englischsprachig)
Third Quarter and First Nine Months 2023 Financial Results and Business Updates – Conference Call & Webcast
November 14, 2023
CureVac N.V. (Nasdaq: CVAC) has reported financial results and provided business updates for the third quarter and first nine months of 2023 on Tuesday, November 14, 2023. The company hosted a conference call and webcast on the same day.
Please find the corresponding press release and presentation slides below. A link to the replay of the webcast is available via the link below.